🇺🇸 FDA
Patent

US 8865728

Combinations comprising methotrexate and DHODH inhibitors

granted A61KA61K31/455A61K31/519

Quick answer

US patent 8865728 (Combinations comprising methotrexate and DHODH inhibitors) held by Almirall, S.A. expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/455, A61K31/519, A61K45/06, A61P